Milestone Scientific (MLSS) Equity Average (2011 - 2026)

Milestone Scientific's Equity Average history runs 16 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• In Q1 2026, Equity Average fell 50.49% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $2.5 million (down 50.49% YoY), while the FY2025 annual figure was $4.3 million, down 37.56% from the prior year.
• Equity Average came in at $2.5 million for Q1 2026 at Milestone Scientific, down from $2.7 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $15.5 million in Q1 2022 to a low of $2.5 million in Q1 2026.
• A 5-year average of $7.7 million and a median of $7.6 million in 2024 frame the typical range for Equity Average.
• Across the five-year window, Equity Average climbed 3.27% in 2024 and sank 61.19% in 2025, its largest moves.
• Milestone Scientific's Equity Average stood at $10.6 million in 2022, then decreased by 29.18% to $7.5 million in 2023, then fell by 13.0% to $6.5 million in 2024, then sank by 58.92% to $2.7 million in 2025, then declined by 4.93% to $2.5 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $2.5 million, $2.7 million, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison